Elesta develops innovative hi-tech therapeutic applications for interventional medicine. Our main product is
EchoLaser: the first and unique integrated Laser-Ultrasound system allowing diagnosis and micro-invasive
treatment of benign and malignant tumours. Laser light transmitted through extremely thin optical fibers
induces a cytoreduction process on benign lesions or destroys cancerous tissue of malignant lesions.
Core EchoLaser clinical applications are:
ModìLite – lesions of the neck, such as benign thyroid nodules and metastatic lymph nodes.
SoracteLite – urinary system disorders like Benign Prostatic Hyperplasia (BPH), low-risk localized Prostate
Cancer (PCa) and Kidney Cancer.
PBLite – primary and secondary malignant liver cancers